# Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

> **NCT06833788** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2860 (estimated)

## Conditions studied

- Postpartum Depression (PPD)

## Interventions

- **DRUG:** Ferric carboxymaltose IV
- **DRUG:** TIMOFÉROL®

## Key facts

- **NCT ID:** NCT06833788
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2028-06
- **Final completion:** 2028-10
- **Target enrollment:** 2860 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833788, "Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06833788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*